| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 18/11/2021 | VACINA CONTRA SARS - COV 2 - 06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 426 |
| 22/11/2021 | VACINA CONTRA SARS-COV2- 06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 270 |
| 25/11/2021 | VACINA CONTRA SARS COV2-06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 90 | 0 | 0 | 0 | 0 | 276 |
| 06/12/2021 | VACINA CONTRA SARS - COV - 06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 150 |
| 10/12/2021 | VACINA CONTRA SARS-COV2- 05 DOSES | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 20 |
| 14/12/2021 | VACINA CONTRA SARS - COV2 - 06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 54 |
| 14/12/2021 | VACINA CONTRA SARS - COV2 - 05 DOSES | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 90 |
| 14/12/2021 | VACINA CONTRA SARS COV 2 - 05 DOSES | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 20 |
| 23/12/2021 | VACINA CONTRA SARS-COV2- 05 DOSES | Covid-19-AstraZeneca | 0 | 0 | 0 | 0 | 0 | 19 |
| 03/01/2022 | D1, D2 E REF | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 204 |
| 10/01/2022 | D1, D2 e REF | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 330 |
| 15/01/2022 | VACINA CONTRA SARS-COV2- PEDIÁTRICA- 10 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 60 |
| 17/01/2022 | D1, D2 E REF | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 426 |
| 17/01/2022 | REF | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 45 |
| 18/01/2022 | D1 | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 60 | 0 | 0 | 0 | 0 | 60 |
| 24/01/2022 | VACINA CONTRA SARS-COV2- 06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 1.104 |
| 26/01/2022 | VACINA CONTRA SARS-COV2- 01 DOSE | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 34 |
| 26/01/2022 | VACINA CONTRA SARS-COV2-PEDIÁTRICA- 10 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 80 |
| 31/01/2022 | VACINA CONTRA SARS COV 2 06 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 120 |
| 03/02/2022 | VACINA CONTRA SARS -COV2-10 DOSES | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 120 |
| 03/02/2022 | VACINA CONTRA SARS-C0V2- PEDIÁTRICA- 10 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 80 |
| 07/02/2022 | VACINA CONTRA SARS-COV2- 01 DOSE | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 10 |
| 11/02/2022 | VACINA CONTRA SARS-COV2- PEDIÁTRICA-10 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 80 |
| 11/02/2022 | VACINA CONTRA SARS-COV2- 01 DOSE | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 10 |
| 14/02/2022 | VACINA CONTRA SARS-COV2- 05 DOSES | Covid-19-AstraZeneca | 0 | 0 | 0 | 0 | 0 | 50 |
| 14/02/2022 | VACINA CONTRA SARS-COV2- 05 DOSES | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 20 |
| 21/02/2022 | VACINA CONTRA SARS-COV2- 01 DOSE | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 238 |
| 21/02/2022 | VACINA CONTRA SARS-COV2- 10 DOSES | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 60 |
| 22/02/2022 | VACINA CONTRA SARS-COV2- 01 DOSE | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 20 |
| 22/02/2022 | VACINA CONTRA SARS-COV2- 05 DOSES | Vacina Covid-19 - Covishield | 0 | 0 | 0 | 0 | 0 | 400 |
